Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis

Antioxidants and Redox Signaling

Volumn 7, Issue 3-4, 2005, Pages 425-431

  Takahashi, Yoshitaka ^a   Zhu, Hong ^b   Yoshimoto, Tanihiro ^b  

^a OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LEUKOTRIENE; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CYTOSOL; ENDOCYTOSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; INFLAMMATION; LIPID DEGRADATION; LIPID OXIDATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARTERIOSCLEROSIS; INFLAMMATION; LDL-RECEPTOR RELATED PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION;

EID: 14044268133     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.425     Document Type: Review

References (73)

1. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996.
2. Belkner J, Wiesner R, Rathman J, Barnett J, Sigal E, and Kuhn H. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem 213: 251-261, 1993.
3. Belkner J, Stender H, and Kuhn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesteryl esters, and this reaction does not require vitamin E. J Biol Chem 273: 23225-23232, 1998.
4. Berliner JA and Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996.
5. Boucher P, Gotthardt M, Li WP, Anderson RG, and Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300: 329-332, 2003.
6. Brash AR. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274: 23679-23682, 1999.
7. Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
8. Burke JA, Levi R, Guo ZG, and Corey EJ. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther 221: 235-241, 1982.
9. Cathcart MK, Li Q, and Chisolm GM 3rd. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL. J Lipid Res 36: 1857-1865, 1995.
10. Chisolm GM, Hazen SL, Fox PL, and Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 274: 25959-25962, 1999.
11. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, and Funk CD. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 103: 1597-1604, 1999.
12. Dahlen SE, Bjork J, Hedqvist P, Arfors KE, Hammarstrom S, Lindgren JA, and Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A 78: 3887-3891, 1981.
13. De Caterina R and Zampolli A. From asthma to atherosclerosis - 5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 350: 4-7, 2004.
14. Funk CD. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304: 65-84, 1996.
15. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875, 2001.
16. Funk CD and Cyrus T. 12/15-Lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med 11: 116-124, 2001.
17. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, and Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23, 2003.
18. Goldstein JL and Brown MS. Lipoprotein receptors and the control of plasma LDL cholesterol levels. Eur Heart J 13 Suppl B: 34-36, 1992.
19. Hagihara H, Nomoto A, Mutoh S, Yamaguchi I, and Ono T. Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery. Atherosclerosis 91: 107-116, 1991.
20. Hajjar DP and Haberland ME. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem 272: 22975-22978, 1997.
21. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, and Sigal E. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 20: 2100-2105, 2000.
22. Heinecke JW, Rosen H, and Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscule cells in culture. J Clin Invest 74: 1890-1894, 1984.
23. Henriksen T, Mahoney EM, and Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 78: 6499-6503, 1981.
24. Herz J and Strickland DK. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784, 2001.
25. Hiltunen TP and Yla-Herttuala S. Expression of lipoprotein receptors in atherosclerotic lesions. Atherosclerosis 137 Suppl: S81-S88, 1998.
26. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, and Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272: 20982-20985, 1997.
27. Jian B, de la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, and Rothblat GH. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 273: 5599-5606, 1998.
28. Kamohara M, Takasaki J, Matsumoto M, Matsumoto S, Saito T, Soga T, Matsushime H, and Furuichi K. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. Biochem Biophys Res Commun 287: 1088-1092, 2001.
29. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, and Yokode M. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 947: 199-205, 2001.
30. Kondo K, Umemura K, Ohmura T, Hashimoto H, and Nakashima M. Suppression of intimal hyperplasia by a 5-lipoxygenase inhibitor, MK-886: studies with a photochemical model of endothelial injury. Thromb Haemost 79: 635-639, 1998.
31. Kuhn H and Thiele BJ. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 449: 7-11, 1999.
32. Kuhn H, Belkner J, Suzuki H, and Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res 35: 1749-1759, 1994.
33. Kuhn H, Heydeck D, Hugou I, and Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99: 888-893, 1997.
34. Kuhn H, Anton M, Gerth C, and Habenicht A. Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog. Arterioscler Thromb Vasc Biol 23: 1072-1076, 2003.
35. Lusis AJ, Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, and Tall AR. Atherosclerosis scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. Nature 407: 233-241, 2000.
36. McNally AK, Chisolm GM 3rd, Morel DW, and Cathcart MK. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J Immunol 145: 254-259, 1990.
37. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ, and Shih W. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91: 120-126, 2002.
38. Mellor EA, Austen KF, and Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195: 583-592, 2002.
39. Miller YI, Chang MK, Funk CD, Feramisco JR, and Witztum JL. 12/15-Lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells. J Biol Chem 276: 19431-19439, 2001.
40. Moestrup SK, Gliemann J, Pallesen G, Tangirala RK, Mol MJ, and Steinberg D. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269: 375-382, 1992.
41. Natarajan R, Reddy MA, Malik KU, Fatima S, and Khan BV Signaling mechanisms of nuclear factor-kappaB-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 1408-1413, 2001.
42. Niki E and Noguchi N. Effects of antioxidants against atherosclerosis. Mol Cell Biochem 234-235: 19-25, 2002.
43. Pech-Amsellem MA, Myara I, Pico I, Maziere C, Maziere JC, and Moatti N. Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926. Experientia 52: 234-238, 1996.
44. Radmark O. 5-Lipoxygenase-derived leukotrienes: mediators also of atherosclerotic inflammation. Arterioscler Thromb Vasc Biol 23: 1140-1142, 2003.
45. Ralph P and Nakoinz I. Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257: 393-394, 1975.
46. Rankin SM, Parthasarathy S, and Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 32: 449-456, 1991.
47. Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, and Natarajan R. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem 277: 9920-9928, 2002.
48. Rohlmann A, Gotthardt M, Hammer RE, and Herz J. Inducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101: 689-695, 1998.
49. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126, 1999.
50. Sakashita T, Takahashi Y, Kinoshita T, and Yoshimoto T. Essential involvement of 12-lipoxygenase in regiospecific and stereospecific oxidation of low density lipoprotein by macrophages. Eur J Biochem 265: 825-831, 1999.
51. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, and Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176, 1987.
52. Shen J, Kuhn H, Petho-Schramm A, and Chan L. Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J 9: 1623-1631, 1995.
53. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kuhn H, Radmark O, Samuelsson B, and Habenicht AJ. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A 100: 1238-1243, 2003.
54. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, and Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924, 1989.
55. Steinbrecher UP. Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim Biophys Acta 959: 20-30, 1988.
56. Steinbrecher UP, Parthasarathy S, Leake DS, Witzum JL, and Steinberg D. Modification of low density lipoprotein by endthelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 81: 3883-3887, 1984.
57. Sun DX and Funk CD. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages - enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271: 24055-24062, 1996.
58. Swarnakar S, Beers J, Strickland DK, Azhar S, and Williams DL. The apolipoprotein E-dependent low density lipoprotein cholesteryl ester selective uptake pathway in murine adrenocortical cells involves chondroitin sulfate proteoglycans and an alpha 2-macroglobulin receptor. J Biol Chem 276: 21121-21128, 2001.
59. Takahashi Y and Yoshimoto T. What are the functions of mammalian 8-, 12-, and 15-lipoxygenases? Res Adv Cancer 2: 221-229, 2002.
60. Tangirala RK, Mol MJ, and Steinberg D. Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor. J Lipid Res 37: 835-843, 1996.
61. Walther M, Anton M, Wiedmann M, Fletterick R, and Kuhn H. The N-terminal domain of the reticulocyte-type 15-lipoxygenase is not essential for enzymatic activity but contains determinants for membrane binding. J Biol Chem 277: 27360-27366, 2002.
62. Walther M, Wiesner R, and Kuhn H. Investigations into calcium-dependent membrane association of 15-lipoxygenase-1. Mechanistic roles of surface-exposed hydrophobic amino acids and calcium. J Biol Chem 279: 3717-3725, 2004.
63. Wickelgren I. Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation. Science 303: 941, 2004.
64. Willnow TE, Tangirala RK, Mol MJ, and Steinberg D. The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism. J Mol Med 77: 306-315, 1999.
65. Witztum JL and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991.
66. Woods JW, Evans JF, Ethier D, Scott S, Vickers PJ, Hearn L, Heibein JA, Charleson S, and Singer I. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 178: 1935-1946, 1993.
67. Xu W, Takahashi Y, Sakashita T, Iwasaki T, Hattori H, and Yoshimoto T. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase. J Biol Chem 276: 36454-36459, 2001.
68. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128: 117-131, 1992.
69. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, and Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A 87: 6959-6963, 1990.
70. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, and Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. J Clin Invest 87: 1146-1152, 1991.
71. Yoshimoto T and Takahashi Y Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat 68-69: 245-262, 2002.
72. Zhao L, Cuff CA, Moss E, Wille U, Cyrus T, Klein EA, Pratico D, Rader DJ, Hunter CA, Pure E, and Funk CD. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277: 35350-35356, 2002.
73. Zhu H, Takahashi Y, Xu W, Kawajiri H, Murakami T, Yamamoto M, Iseki S, Iwasaki T, Hattori H, and Yoshimoto T. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J Biol Chem 278: 13350-13355, 2003.